Roger Clemens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Roger Clemens has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- A. Satyanarayan Naidu
Global Nutrition Healthcare Council (GNHC) Mission-COVID, Yorba Linda, USA
8 shared publications - Peter Pressman
University of Maine, 5728 Fernald Hall, Room 201, Orono, ME, 04469, USA
8 shared publications Peter Pressman
Department of Sociology University of Maine United States
5 shared publications- Sreus A. G. Naidu
N-terminus Research Laboratory, Yorba Linda, CA, USA
5 shared publications - Analeise Guild
Global Gastroschisis Foundation, USA
3 shared publications - Andrea Gilbaugh
Clinical Nutrition, Stanford Medicine Children's Health, Palo Alto, California, USA
3 shared publications
Latest Publications
- 7 September 2026
- Published by Wolters Kluwer Health in Nutrition Today
Closure of the Strait and Hunger
Was not provided for this article.
- 7 September 2026
- Published by Wolters Kluwer Health in Nutrition Today
Closure of the Strait and Hunger
Was not provided for this article.
- 13 August 2026
- Published by Wolters Kluwer Health in Nutrition Today
From Attitudes to Actions
Social media platforms have become major sources of nutrition and health information for young adults, exposing users to streams of diet-related messaging, supplement promotion, and body-focused content. Existing research consistently links this exposure to outcomes such as body dissatisfaction, social comparison, and disordered eating tendencies; however, the extent to which these effects may translate into measurable dietary behaviors remains less clear. This review examines current evidence regarding the behavioral translation of social media nutrition content among young adults, focusing on supplement use, restrictive eating practices, altered meal patterns, and food-related decision-making. We propose a conceptual framework in which dietary behaviors emerge through the interaction of 3 overlapping domains: content exposure, psychological mechanisms, and platform engagement factors. Within this framework, social media functions not only as an information source but as a behavioral environment that normalizes dietary “behavioral templates” through content amplification, peer validation, and actionable guidance. Current evidence suggests that supplement adoption and restrictive dieting behaviors represent the strongest documented behavioral outcomes associated with social media exposure, while evidence for altered meal patterns and food purchasing behaviors remains limited. The present review also identifies methodological limitations across the literature, including reliance on cross-sectional designs, imprecise exposure measurement, short follow-up periods, and dependence on self-reported outcomes rather than objective behavioral measures. Future research should prioritize longitudinal and experimental designs, passive exposure tracking, and objective dietary measures. Understanding how social media content shapes real-world dietary behavior is essential for informing public health interventions, health literacy initiatives, and platform accountability policies targeting young adults.
- 13 August 2026
- Published by Wolters Kluwer Health in Nutrition Today
From Attitudes to Actions
Social media platforms have become major sources of nutrition and health information for young adults, exposing users to streams of diet-related messaging, supplement promotion, and body-focused content. Existing research consistently links this exposure to outcomes such as body dissatisfaction, social comparison, and disordered eating tendencies; however, the extent to which these effects may translate into measurable dietary behaviors remains less clear. This review examines current evidence regarding the behavioral translation of social media nutrition content among young adults, focusing on supplement use, restrictive eating practices, altered meal patterns, and food-related decision-making. We propose a conceptual framework in which dietary behaviors emerge through the interaction of 3 overlapping domains: content exposure, psychological mechanisms, and platform engagement factors. Within this framework, social media functions not only as an information source but as a behavioral environment that normalizes dietary “behavioral templates” through content amplification, peer validation, and actionable guidance. Current evidence suggests that supplement adoption and restrictive dieting behaviors represent the strongest documented behavioral outcomes associated with social media exposure, while evidence for altered meal patterns and food purchasing behaviors remains limited. The present review also identifies methodological limitations across the literature, including reliance on cross-sectional designs, imprecise exposure measurement, short follow-up periods, and dependence on self-reported outcomes rather than objective behavioral measures. Future research should prioritize longitudinal and experimental designs, passive exposure tracking, and objective dietary measures. Understanding how social media content shapes real-world dietary behavior is essential for informing public health interventions, health literacy initiatives, and platform accountability policies targeting young adults.
- Open Access
- 5 August 2025
- Published by MDPI AG in Preprints.org
FDA Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 2, Regulatory and Safety Considerations
Operation Stork Speed was launched to modernize infant formula oversight after 2022 shortages and other evidence of supply chain and safety issues. Current Food and Drug Administration(FDA) processes to regulate formula are at times slow and complex, making it difficult for new formulas to enter the market. One key pathway to adding bioactive substances or other compounds to infant formula is via the Generally Recognized as Safe (GRAS) route. GRAS and food additive pathways require safety data, but food additive petitions require more safety information and cannot be marketed until FDA approval is granted. Concern has been expressed about the safety of formula related to the possible presence of toxic substances in formula. Heavy metals, PFAS and other toxins can be found in formulas and infants can be at increased risk of effects. US lacks enforceable limits, unlike EU, Canadian and Australian counterparts. To enhance the regulatory environment for infant formula, legislative updates, supply chain transparency and alignment with global safety standards are needed.
- 5 August 2025
- Published by MDPI AG in Preprints.org
Open AccessFDA Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 2, Regulatory and Safety Considerations
Operation Stork Speed was launched to modernize infant formula oversight after 2022 shortages and other evidence of supply chain and safety issues. Current Food and Drug Administration(FDA) processes to regulate formula are at times slow and complex, making it difficult for new formulas to enter the market. One key pathway to adding bioactive substances or other compounds to infant formula is via the Generally Recognized as Safe (GRAS) route. GRAS and food additive pathways require safety data, but food additive petitions require more safety information and cannot be marketed until FDA approval is granted. Concern has been expressed about the safety of formula related to the possible presence of toxic substances in formula. Heavy metals, PFAS and other toxins can be found in formulas and infants can be at increased risk of effects. US lacks enforceable limits, unlike EU, Canadian and Australian counterparts. To enhance the regulatory environment for infant formula, legislative updates, supply chain transparency and alignment with global safety standards are needed.
- Open Access
- 4 August 2025
- Published by MDPI AG in Preprints.org
FDA Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 3, Marketing of Infant Formulas, Breastfeeding Support, Hypoallergenic Formulas, and Nutrition for Preterm Infants
The U.S. formula industry utilizes aggressive marketing strategies which exploit parental anxieties, undermine breastfeeding, violate ethical international standards, all of which contribute to early formula introduction and disparities in breastfeeding. Additionally, misleading or complex labeling contribute to caregiver and provider confusion regarding the content of formulas. A centralized, Food and Drug Administration (FDA)-maintained database of infant formulas could support caregivers and healthcare professionals in countering misinformation and making evidence-based decisions. Human milk remains the gold standard for infant nutrition, with strong evidence supporting its role in reducing morbidity and mortality, especially in the Neonatal Intensive Care Unit (NICU). Despite this, disparities persist in breastfeeding rates, particularly among Black and Hispanic mothers. These are driven by structural barriers, including lack of paid parental leave and inadequate lactation support. Donor human milk (DHM) is the recommended alternative for high-risk infants in the NICU when mother’s own milk (MOM) is unavailable. However, due to lack of federal funding and oversight, high cost and inconsistent insurance coverage, the use of DHM use is limited, especially in safety-net hospitals. Specialized hypoallergenic and metabolic formulas are essential for managing medical conditions including cow’s milk-protein allergy and inborn errors of metabolism. These are regulated as exempt formulas but must meet rigorous clinical standards. In the NICU, adequate early nutrition for preterm infants is crucial to reduce morbidity and mortality and improve long-term neurodevelopmental outcomes. Human milk fortifiers (HMFs) are composed of similar ingredients as infant formula and are used to improve the nutritional content feedings given in the NICU and post-discharge. The use of live biotherapeutic products (LBPs) or probiotics as additives to preterm infants have been demonstrated in multiple studies to reduce the incidence of NEC, late-onset sepsis, and all-cause mortality.
- 4 August 2025
- Published by MDPI AG in Preprints.org
Open AccessFDA Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 3, Marketing of Infant Formulas, Breastfeeding Support, Hypoallergenic Formulas, and Nutrition for Preterm Infants
The U.S. formula industry utilizes aggressive marketing strategies which exploit parental anxieties, undermine breastfeeding, violate ethical international standards, all of which contribute to early formula introduction and disparities in breastfeeding. Additionally, misleading or complex labeling contribute to caregiver and provider confusion regarding the content of formulas. A centralized, Food and Drug Administration (FDA)-maintained database of infant formulas could support caregivers and healthcare professionals in countering misinformation and making evidence-based decisions. Human milk remains the gold standard for infant nutrition, with strong evidence supporting its role in reducing morbidity and mortality, especially in the Neonatal Intensive Care Unit (NICU). Despite this, disparities persist in breastfeeding rates, particularly among Black and Hispanic mothers. These are driven by structural barriers, including lack of paid parental leave and inadequate lactation support. Donor human milk (DHM) is the recommended alternative for high-risk infants in the NICU when mother’s own milk (MOM) is unavailable. However, due to lack of federal funding and oversight, high cost and inconsistent insurance coverage, the use of DHM use is limited, especially in safety-net hospitals. Specialized hypoallergenic and metabolic formulas are essential for managing medical conditions including cow’s milk-protein allergy and inborn errors of metabolism. These are regulated as exempt formulas but must meet rigorous clinical standards. In the NICU, adequate early nutrition for preterm infants is crucial to reduce morbidity and mortality and improve long-term neurodevelopmental outcomes. Human milk fortifiers (HMFs) are composed of similar ingredients as infant formula and are used to improve the nutritional content feedings given in the NICU and post-discharge. The use of live biotherapeutic products (LBPs) or probiotics as additives to preterm infants have been demonstrated in multiple studies to reduce the incidence of NEC, late-onset sepsis, and all-cause mortality.
- Open Access
- 4 August 2025
- Published by MDPI AG in Preprints.org
FDA Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 1, Nutrient Considerations
Operation Stork Speed, launched by the Food and Drug Administration(FDA) in March 2025, represents a comprehensive initiative to update infant formula regulations that have remained largely unchanged since the 1980’s. This expert panel review addresses recommendations for nutrients considering four decades of accumulated scientific evidence since then. Current FDA fatty acid regulations specify only total fat content and minimum linoleic acid requirements despite substantial international consensus on polyunsaturated fatty acid specifications. Evidence strongly supports establishing maximum linoleic acid levels and docosahexaenoic acid (DHA) and arachidonic acid (ARA) requirements, reflecting the critical role of omega-3 fatty acids in neurocognitive development and visual acuity. The panel emphasizes that saturated and monounsaturated fatty acids comprise over 80% of human milk fatty acids, while acknowledging recent concerns about seed oils and supporting balanced PUFA formulations. Carbohydrate composition presents significant concerns, as over half of US formulas contain glucose polymers (e.g. corn syrup solids) despite lactose being the primary carbohydrate energy source in human milk. Observational studies link corn syrup-based formulas to multiple possible health risks, including excess weight gain, warranting reconsideration of the value of non-lactose carbohydrate substitutions in formulas for healthy children. Protein content recommendations support decreasing the upper range of allowable intake, aligning with European standards and addressing concerns about excessive protein intake contributing to later obesity risk. Micronutrient evaluation reveals the need to reduce the iron content in routine formulas to lower levels, consistent with European Food Safety Authority recommendations and emerging safety data and a need to set upper limits for the concentration of calcium and phosphorus. Overall, infant formula is a healthy product and has many decades of successfully feeding infants. These comprehensive updates aim to more closely align US infant formula regulations with current scientific understanding and international standards while supporting optimal infant growth, development, and long-term health outcomes.
- 4 August 2025
- Published by MDPI AG in Preprints.org
Open AccessFDA Expert Panel on Infant Formula “Operation Stork Speed” June 2025: Part 1, Nutrient Considerations
Operation Stork Speed, launched by the Food and Drug Administration(FDA) in March 2025, represents a comprehensive initiative to update infant formula regulations that have remained largely unchanged since the 1980’s. This expert panel review addresses recommendations for nutrients considering four decades of accumulated scientific evidence since then. Current FDA fatty acid regulations specify only total fat content and minimum linoleic acid requirements despite substantial international consensus on polyunsaturated fatty acid specifications. Evidence strongly supports establishing maximum linoleic acid levels and docosahexaenoic acid (DHA) and arachidonic acid (ARA) requirements, reflecting the critical role of omega-3 fatty acids in neurocognitive development and visual acuity. The panel emphasizes that saturated and monounsaturated fatty acids comprise over 80% of human milk fatty acids, while acknowledging recent concerns about seed oils and supporting balanced PUFA formulations. Carbohydrate composition presents significant concerns, as over half of US formulas contain glucose polymers (e.g. corn syrup solids) despite lactose being the primary carbohydrate energy source in human milk. Observational studies link corn syrup-based formulas to multiple possible health risks, including excess weight gain, warranting reconsideration of the value of non-lactose carbohydrate substitutions in formulas for healthy children. Protein content recommendations support decreasing the upper range of allowable intake, aligning with European standards and addressing concerns about excessive protein intake contributing to later obesity risk. Micronutrient evaluation reveals the need to reduce the iron content in routine formulas to lower levels, consistent with European Food Safety Authority recommendations and emerging safety data and a need to set upper limits for the concentration of calcium and phosphorus. Overall, infant formula is a healthy product and has many decades of successfully feeding infants. These comprehensive updates aim to more closely align US infant formula regulations with current scientific understanding and international standards while supporting optimal infant growth, development, and long-term health outcomes.
- Open Access
- 6 May 2024
- Published by Springer Nature in npj Science of Food
- Vol. 8 (1) , 1
Author Correction: Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
- 6 May 2024
- Published by Springer Nature in npj Science of Food
- Vol. 8 (1) , 1
Open AccessAuthor Correction: Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
- Open Access
- 30 March 2024
- Published by Springer Nature in npj Science of Food
- Vol. 8 (1) , 1-48
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
SARS‐CoV‐2, the etiological agent of COVID-19, is devoid of any metabolic capacity; therefore, it is critical for the viral pathogen to hijack host cellular metabolic machinery for its replication and propagation. This single-stranded RNA virus with a 29.9 kb genome encodes 14 open reading frames (ORFs) and initiates a plethora of virus–host protein–protein interactions in the human body. These extensive viral protein interactions with host-specific cellular targets could trigger severe human metabolic reprogramming/dysregulation (HMRD), a rewiring of sugar-, amino acid-, lipid-, and nucleotide-metabolism(s), as well as altered or impaired bioenergetics, immune dysfunction, and redox imbalance in the body. In the infectious process, the viral pathogen hijacks two major human receptors, angiotensin-converting enzyme (ACE)-2 and/or neuropilin (NRP)-1, for initial adhesion to cell surface; then utilizes two major host proteases, TMPRSS2 and/or furin, to gain cellular entry; and finally employs an endosomal enzyme, cathepsin L (CTSL) for fusogenic release of its viral genome. The virus-induced HMRD results in 5 possible infectious outcomes: asymptomatic, mild, moderate, severe to fatal episodes; while the symptomatic acute COVID-19 condition could manifest into 3 clinical phases: (i) hypoxia and hypoxemia (Warburg effect), (ii) hyperferritinemia (‘cytokine storm’), and (iii) thrombocytosis (coagulopathy). The mean incubation period for COVID-19 onset was estimated to be 5.1 days, and most cases develop symptoms after 14 days. The mean viral clearance times were 24, 30, and 39 days for acute, severe, and ICU-admitted COVID-19 patients, respectively. However, about 25–70% of virus-free COVID-19 survivors continue to sustain virus-induced HMRD and exhibit a wide range of symptoms that are persistent, exacerbated, or new ‘onset’ clinical incidents, collectively termed as post-acute sequelae of COVID-19 (PASC) or long COVID. PASC patients experience several debilitating clinical condition(s) with >200 different and overlapping symptoms that may last for weeks to months. Chronic PASC is a cumulative outcome of at least 10 different HMRD-related pathophysiological mechanisms involving both virus-derived virulence factors and a multitude of innate host responses. Based on HMRD and virus-free clinical impairments of different human organs/systems, PASC patients can be categorized into 4 different clusters or sub-phenotypes: sub-phenotype-1 (33.8%) with cardiac and renal manifestations; sub-phenotype-2 (32.8%) with respiratory, sleep and anxiety disorders; sub-phenotype-3 (23.4%) with skeleto-muscular and nervous disorders; and sub-phenotype-4 (10.1%) with digestive and pulmonary dysfunctions. This narrative review elucidates the effects of viral hijack on host cellular machinery during SARS-CoV-2 infection, ensuing detrimental effect(s) of virus-induced HMRD on human metabolism, consequential symptomatic clinical implications, and damage to multiple organ systems; as well as chronic pathophysiological sequelae in virus-free PASC patients. We have also provided a few evidence-based, human randomized controlled trial (RCT)-tested, precision nutrients to reset HMRD for health recovery of PASC patients.
- 30 March 2024
- Published by Springer Nature in npj Science of Food
- Vol. 8 (1) , 1-48
Open AccessPrecision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
SARS‐CoV‐2, the etiological agent of COVID-19, is devoid of any metabolic capacity; therefore, it is critical for the viral pathogen to hijack host cellular metabolic machinery for its replication and propagation. This single-stranded RNA virus with a 29.9 kb genome encodes 14 open reading frames (ORFs) and initiates a plethora of virus–host protein–protein interactions in the human body. These extensive viral protein interactions with host-specific cellular targets could trigger severe human metabolic reprogramming/dysregulation (HMRD), a rewiring of sugar-, amino acid-, lipid-, and nucleotide-metabolism(s), as well as altered or impaired bioenergetics, immune dysfunction, and redox imbalance in the body. In the infectious process, the viral pathogen hijacks two major human receptors, angiotensin-converting enzyme (ACE)-2 and/or neuropilin (NRP)-1, for initial adhesion to cell surface; then utilizes two major host proteases, TMPRSS2 and/or furin, to gain cellular entry; and finally employs an endosomal enzyme, cathepsin L (CTSL) for fusogenic release of its viral genome. The virus-induced HMRD results in 5 possible infectious outcomes: asymptomatic, mild, moderate, severe to fatal episodes; while the symptomatic acute COVID-19 condition could manifest into 3 clinical phases: (i) hypoxia and hypoxemia (Warburg effect), (ii) hyperferritinemia (‘cytokine storm’), and (iii) thrombocytosis (coagulopathy). The mean incubation period for COVID-19 onset was estimated to be 5.1 days, and most cases develop symptoms after 14 days. The mean viral clearance times were 24, 30, and 39 days for acute, severe, and ICU-admitted COVID-19 patients, respectively. However, about 25–70% of virus-free COVID-19 survivors continue to sustain virus-induced HMRD and exhibit a wide range of symptoms that are persistent, exacerbated, or new ‘onset’ clinical incidents, collectively termed as post-acute sequelae of COVID-19 (PASC) or long COVID. PASC patients experience several debilitating clinical condition(s) with >200 different and overlapping symptoms that may last for weeks to months. Chronic PASC is a cumulative outcome of at least 10 different HMRD-related pathophysiological mechanisms involving both virus-derived virulence factors and a multitude of innate host responses. Based on HMRD and virus-free clinical impairments of different human organs/systems, PASC patients can be categorized into 4 different clusters or sub-phenotypes: sub-phenotype-1 (33.8%) with cardiac and renal manifestations; sub-phenotype-2 (32.8%) with respiratory, sleep and anxiety disorders; sub-phenotype-3 (23.4%) with skeleto-muscular and nervous disorders; and sub-phenotype-4 (10.1%) with digestive and pulmonary dysfunctions. This narrative review elucidates the effects of viral hijack on host cellular machinery during SARS-CoV-2 infection, ensuing detrimental effect(s) of virus-induced HMRD on human metabolism, consequential symptomatic clinical implications, and damage to multiple organ systems; as well as chronic pathophysiological sequelae in virus-free PASC patients. We have also provided a few evidence-based, human randomized controlled trial (RCT)-tested, precision nutrients to reset HMRD for health recovery of PASC patients.
- Open Access
- 30 June 2023
- Published by International Society for Nutraceuticals & Functional Foods (ISNFF) in Journal of Food Bioactives
- Vol. 22
A Commentary on Millets for Enhancing Agri-economy, Nutrition, Environmental, and Sustainable Development Goals
The IUFoST Scientific Roundtable celebrated the International Year of Millets 2023 by convening an international team of experts to discuss the value of millets relative to agri-economy, nutrition, bioactives, environmental and our delivery on the global development agenda and its sustainable development goals (SDGs). The experts advanced critical analyses that suggested this semi-arid crop, grown primarily in the tropics of Asia and Africa can be an important contributor to improving food and nutrition security. Importantly, millets are a major source of energy and protein for about 130 million people in sub-Saharan Africa. Many in vitro and in vivo (mouse) studies plus a few meta-analyses and systematic reviews suggest millets and their respective components may contribute to the reduction of an array of non-communicable diseases, especially in marginal and harsh environments. Yet these kinds of evidence need to be substantiated by rigorous, well-designed clinical studies such that there is stronger support for millets contributing to global health. In addition, improvements and adoption of technologies that provide a low carbon and water footprint may contribute to consumer acceptance of millets.
- 30 June 2023
- Published by International Society for Nutraceuticals & Functional Foods (ISNFF) in Journal of Food Bioactives
- Vol. 22
Open AccessA Commentary on Millets for Enhancing Agri-economy, Nutrition, Environmental, and Sustainable Development Goals
The IUFoST Scientific Roundtable celebrated the International Year of Millets 2023 by convening an international team of experts to discuss the value of millets relative to agri-economy, nutrition, bioactives, environmental and our delivery on the global development agenda and its sustainable development goals (SDGs). The experts advanced critical analyses that suggested this semi-arid crop, grown primarily in the tropics of Asia and Africa can be an important contributor to improving food and nutrition security. Importantly, millets are a major source of energy and protein for about 130 million people in sub-Saharan Africa. Many in vitro and in vivo (mouse) studies plus a few meta-analyses and systematic reviews suggest millets and their respective components may contribute to the reduction of an array of non-communicable diseases, especially in marginal and harsh environments. Yet these kinds of evidence need to be substantiated by rigorous, well-designed clinical studies such that there is stronger support for millets contributing to global health. In addition, improvements and adoption of technologies that provide a low carbon and water footprint may contribute to consumer acceptance of millets.
- Open Access
- 15 June 2023
- Published by Qeios Ltd
Review of: "[Review] Sarcopenia in Coronavirus Disease (COVID-19): All to Know from Basic to Nutritional Interventions from Hospital to Home"
Regarding the “sarcopenia and COVID” paper…the poor use of English markedly detracts from the hypothesis of the manuscript. From this reviewer’s perspective, the paper needs to be rewritten before extensive review is possible. In addition, the pote...
- 15 June 2023
- Published by Qeios Ltd
Open AccessReview of: "[Review] Sarcopenia in Coronavirus Disease (COVID-19): All to Know from Basic to Nutritional Interventions from Hospital to Home"
Regarding the “sarcopenia and COVID” paper…the poor use of English markedly detracts from the hypothesis of the manuscript. From this reviewer’s perspective, the paper needs to be rewritten before extensive review is possible. In addition, the pote...
- 1 November 2022
- Published by Wolters Kluwer Health in Nutrition Today
- Vol. 57 (6) , 309-316
No Smell, No Taste—Dealing With a “Senseless” Phase of the Pandemic
The SARS-CoV-2 infection alters smell and taste sensations in many patients. These 2 neurosensory impairments, namely, (1) the loss of smell, an olfactory dysfunction (OD) or anosmia, and (2) the loss of taste, a gustatory dysfunction (GD) or ageusia, are often the earliest and, sometimes, the only signs in otherwise asymptomatic individuals. Both OD and GD are recognized by the international scientific community as one of the critical symptoms of COVID-19. The prevalence of COVID-19–related OD is higher among women (although less likely to experience severe forms of SARS-CoV-2 infection) than men. The total loss of taste sense or GD is more common among the elderly COVID-19 patients than in the younger population. In “long” COVID or postacute sequelae of COVID-19 (PASC) patients, OD/GD could persist for months to years, depending on the extent of damage caused by the SARS-CoV-2 infection to the olfactory and gustatory systems. Olfactory dysfunction and GD manifestations may severely disrupt quality of life, which includes altered eating habits, loss of appetite, weight change, and loss of pleasure in food consumption, and may further affect psychological well-being, social bonding, altered intimacy, and relationship to self and others. The hedonic value of diet relies exclusively on its flavor; however, the onset of OD/GD during SARS-CoV-2 infection deprives such organoleptic experiences of nutrition. To compensate for these OD/GD issues, the chemosensory focus of COVID-19/PASC patients during dietary consumption may shift toward food texture (to stimulate trigeminal nerves) and food colors (to stimulate brain activity), to sustain appetite as well as enhance the pleasure of eating. Olfactory training with repeated exposure to 4 intense odors twice daily has been a traditional rehabilitation practice to alleviate olfactory impairments in COVID-19. The neurosensory impairments in COVID-19 pathobiology culminate from iron-redox dysregulation, viral-induced host metabolic reprogramming, and host mitochondrial dysfunction. Therefore, nutritional restoration of host metabolic reprogramming and mitochondrial function could provide an effective strategy to reverse iron-redox dysregulation syndrome and combat OD/GD in COVID-19 and PASC patients. Innate regulators of iron-redox homeostasis, such as lactoferrin, heme oxygenase-1, erythropoietin, and hepcidin modulators, could serve as potential interventions for OD/GD recovery.
- 1 November 2022
- Published by Wolters Kluwer Health in Nutrition Today
- Vol. 57 (6) , 309-316
No Smell, No Taste—Dealing With a “Senseless” Phase of the Pandemic
The SARS-CoV-2 infection alters smell and taste sensations in many patients. These 2 neurosensory impairments, namely, (1) the loss of smell, an olfactory dysfunction (OD) or anosmia, and (2) the loss of taste, a gustatory dysfunction (GD) or ageusia, are often the earliest and, sometimes, the only signs in otherwise asymptomatic individuals. Both OD and GD are recognized by the international scientific community as one of the critical symptoms of COVID-19. The prevalence of COVID-19–related OD is higher among women (although less likely to experience severe forms of SARS-CoV-2 infection) than men. The total loss of taste sense or GD is more common among the elderly COVID-19 patients than in the younger population. In “long” COVID or postacute sequelae of COVID-19 (PASC) patients, OD/GD could persist for months to years, depending on the extent of damage caused by the SARS-CoV-2 infection to the olfactory and gustatory systems. Olfactory dysfunction and GD manifestations may severely disrupt quality of life, which includes altered eating habits, loss of appetite, weight change, and loss of pleasure in food consumption, and may further affect psychological well-being, social bonding, altered intimacy, and relationship to self and others. The hedonic value of diet relies exclusively on its flavor; however, the onset of OD/GD during SARS-CoV-2 infection deprives such organoleptic experiences of nutrition. To compensate for these OD/GD issues, the chemosensory focus of COVID-19/PASC patients during dietary consumption may shift toward food texture (to stimulate trigeminal nerves) and food colors (to stimulate brain activity), to sustain appetite as well as enhance the pleasure of eating. Olfactory training with repeated exposure to 4 intense odors twice daily has been a traditional rehabilitation practice to alleviate olfactory impairments in COVID-19. The neurosensory impairments in COVID-19 pathobiology culminate from iron-redox dysregulation, viral-induced host metabolic reprogramming, and host mitochondrial dysfunction. Therefore, nutritional restoration of host metabolic reprogramming and mitochondrial function could provide an effective strategy to reverse iron-redox dysregulation syndrome and combat OD/GD in COVID-19 and PASC patients. Innate regulators of iron-redox homeostasis, such as lactoferrin, heme oxygenase-1, erythropoietin, and hepcidin modulators, could serve as potential interventions for OD/GD recovery.